StonvexLoading…
StonvexStonvexStonvexCore line items from THG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.59B | $6.24B | $5.99B | $5.47B |
Operating Income | $933.00M | $650.10M | $105.60M | $285.10M |
Net Income | $662.50M | $426.00M | $35.30M | $116.00M |
EPS (Diluted) | $18.16 | $11.70 | $0.98 | $3.21 |
Total Assets | $16.95B | $15.27B | $14.61B | $14.00B |
Total Liabilities | $13.37B | $12.43B | $12.15B | $11.66B |
Cash & Equivalents | $1.12B | $435.50M | $316.10M | $305.00M |
Free Cash Flow OCF − CapEx | $1.17B | $796.20M | $349.80M | $704.50M |
Shares Outstanding | 36.50M | 36.40M | 36.10M | 36.10M |